Stimulator of interferon genes (STING)‐activating nanomedicines: Translating innate immune modulation into effective therapy for triple‐negative breast cancer

Documenti analoghi

• Rational Design and Characterization of 5‐Fluorouracil–Loaded Lipid–Polymer Hybrid Nanoparticles for Enhanced Transdermal Delivery in Skin Cancer Therapy
  di: Tenzin Sonam Dongsar, et al.
  Pubblicazione: (2026)
• Ammonia‐Induced Cell Death: A Novel Frontier to Enhance Cancer Immunotherapy
  di: Urushi Rehman, et al.
  Pubblicazione: (2025)
• Targeting c‐Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple‐negative breast cancer
  di: Xiaojie Liang, et al.
  Pubblicazione: (2025)
• Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients
  di: Chiara Massa, et al.
  Pubblicazione: (2024)
• PCDHGB7 inhibits the progression of triple‐negative breast cancer by suppressing XRCC5/MYC‐mediated ribosome biogenesis
  di: Ming Shan, et al.
  Pubblicazione: (2025)